| Deconstructing the peptide-MHC specificity of T cell recognition ME Birnbaum, JL Mendoza, DK Sethi, S Dong, J Glanville, J Dobbins, ... Cell 157 (5), 1073-1087, 2014 | 610 | 2014 |
| Requirements for efficient correction of ΔF508 CFTR revealed by analyses of evolved sequences JL Mendoza, A Schmidt, Q Li, E Nuvaga, T Barrett, RJ Bridges, ... Cell 148 (1), 164-174, 2012 | 289 | 2012 |
| Antigen identification for orphan T cell receptors expressed on tumor-infiltrating lymphocytes MH Gee, A Han, SM Lofgren, JF Beausang, JL Mendoza, ME Birnbaum, ... Cell 172 (3), 549-563. e16, 2018 | 286 | 2018 |
| Insights into cytokine–receptor interactions from cytokine engineering JB Spangler, I Moraga, JL Mendoza, KC Garcia Annual review of immunology 33 (1), 139-167, 2015 | 278 | 2015 |
| Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor OO Onabajo, AR Banday, ML Stanifer, W Yan, A Obajemu, DM Santer, ... Nature Genetics 52 (12), 1283-1293, 2020 | 250 | 2020 |
| The cystic fibrosis-causing mutation ΔF508 affects multiple steps in cystic fibrosis transmembrane conductance regulator biogenesis PH Thibodeau, JM Richardson, W Wang, L Millen, J Watson, JL Mendoza, ... Journal of Biological Chemistry 285 (46), 35825-35835, 2010 | 200 | 2010 |
| Alpha and beta type 1 interferon signaling: passage for diverse biologic outcomes CT Ng, JL Mendoza, KC Garcia, MBA Oldstone Cell 164 (3), 349-352, 2016 | 151 | 2016 |
| Differential induction of interferon stimulated genes between type I and type III interferons is independent of interferon receptor abundance K Pervolaraki, S Rastgou Talemi, D Albrecht, F Bormann, C Bamford, ... PLoS pathogens 14 (11), e1007420, 2018 | 140 | 2018 |
| Structure of the IFNγ receptor complex guides design of biased agonists JL Mendoza, NK Escalante, KM Jude, J Sotolongo Bellon, L Su, ... Nature 567 (7746), 56-60, 2019 | 131 | 2019 |
| The IFN-λ-IFN-λR1-IL-10Rβ complex reveals structural features underlying type III IFN functional plasticity JL Mendoza, WM Schneider, HH Hoffmann, K Vercauteren, KM Jude, ... Immunity 46 (3), 379-392, 2017 | 111 | 2017 |
| T cell receptor cross-reactivity expanded by dramatic peptide–MHC adaptability TP Riley, LM Hellman, MH Gee, JL Mendoza, JA Alonso, KC Foley, ... Nature chemical biology 14 (10), 934-942, 2018 | 90 | 2018 |
| Synthekines are surrogate cytokine and growth factor agonists that compel signaling through non-natural receptor dimers I Moraga, JB Spangler, JL Mendoza, M Gakovic, TS Wehrman, P Krutzik, ... Elife 6, e22882, 2017 | 79 | 2017 |
| Multifarious determinants of cytokine receptor signaling specificity I Moraga, J Spangler, JL Mendoza, KC Garcia Advances in immunology 121, 1-39, 2014 | 73 | 2014 |
| A unique redox-sensing sensor II motif in TorsinA plays a critical role in nucleotide and partner binding L Zhu, L Millen, JL Mendoza, PJ Thomas Journal of Biological Chemistry 285 (48), 37271-37280, 2010 | 61 | 2010 |
| Water and ligand entry in myoglobin: Assessing the speed and extent of heme pocket hydration after CO photodissociation RA Goldbeck, S Bhaskaran, C Ortega, JL Mendoza, JS Olson, J Soman, ... Proceedings of the National Academy of Sciences 103 (5), 1254-1259, 2006 | 61 | 2006 |
| Building an understanding of cystic fibrosis on the foundation of ABC transporter structures JL Mendoza, PJ Thomas Journal of bioenergetics and biomembranes 39, 499-505, 2007 | 60 | 2007 |
| Masking the immunotoxicity of interleukin-12 by fusing it with a domain of its receptor via a tumour-protease-cleavable linker A Mansurov, P Hosseinchi, K Chang, AL Lauterbach, LT Gray, AT Alpar, ... Nature biomedical engineering 6 (7), 819-829, 2022 | 50 | 2022 |
| The intergenic recombinant HLA-B∗ 46: 01 has a distinctive peptidome that includes KIR2DL3 ligands HG Hilton, CP McMurtrey, AS Han, Z Djaoud, LA Guethlein, JH Blokhuis, ... Cell reports 19 (7), 1394-1405, 2017 | 43 | 2017 |
| HLA-B57 micropolymorphism defines the sequence and conformational breadth of the immunopeptidome PT Illing, P Pymm, NP Croft, HG Hilton, V Jojic, AS Han, JL Mendoza, ... Nature communications 9 (1), 4693, 2018 | 42 | 2018 |
| A polymorphic residue that attenuates the antiviral potential of interferon lambda 4 in hominid lineages CGG Bamford, E Aranday-Cortes, IC Filipe, S Sukumar, D Mair, AS Filipe, ... PLoS Pathogens 14 (10), e1007307, 2018 | 31 | 2018 |
